| Literature DB >> 29725598 |
Marco Loffi1, Andrea Santangelo2, Martin Kozel3, Viktor Kocka3, Tomas Budesinsky3, Libor Lisa3, Petr Tousek3.
Abstract
BACKGROUND: Takotsubo cardiomyopathy (TC) aetiology has not been completely understood yet. One proposed pathogenic mechanism was coronary microvascular dysfunction (MVD). This study compared coronary flow and myocardial perfusion in patients with TC, microvascular angina (MVA), and a control group (CG).Entities:
Mesh:
Year: 2018 PMID: 29725598 PMCID: PMC5872669 DOI: 10.1155/2018/5281485
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Baseline characteristics of the patients.
| TC ( | MVA ( | CG ( |
| |
|---|---|---|---|---|
| Age | 67 ± 10 | 65 ± 9 | 64 ± 9 | NS |
| Female | 23 (85%) | 23 (85%) | 23 (85%) | NS |
| Caucasian | 27 (100%) | 27 (100%) | 27 (100%) | NS |
| Hypertension | 15 (55%) | 17 (62%) | 20 (74%) | NS |
| Diabetes Mellitus | 3 (11%) | 5 (18%) | 3 (11%) | NS |
| Hypercholesterolemia | 15 (55%) | 13 (48%) | 16 (59%) | NS |
| Current Smoking | 10 (37%) | 6 (22%) | 8 (30%) | NS |
| EF, % | 35 ± 9 | 58 ± 7 | 57 ± 10 | 0,001/0,001/NS |
| Menopause | 26 (96%) | / | / | / |
| Emotional trigger | 6 (22%) | / | / | / |
| Physical trigger | 11 (40%) | / | / | / |
| Apical pattern | 23 (85%) | / | / | / |
| LVOT obstruction | 3 (11%) | / | / | / |
| Troponin | 355 ± 362 | / | / | / |
| ST-segment elevation | 11 (40%) | / | / | / |
| Prolonged QTc∨ | 9 (33%) | / | / | / |
| EF ≤ 35% | 17 (63%) | / | / | / |
| Inotropic support | 6 (22%) | / | / | / |
| In-hospital death | 3 (11%) | / | / | / |
TC: Takotsubo cardiomyopathy; MVA: microvascular angina; CG: control group; LVOT: left ventricle outflow tract obstruction; EF: ejection fraction. NS: nonsignificant; ∨QT corrected interval above 450 ms in males or above 470 ms in females; ∗ indicates the same result for all the three matches.
Coronary flow evaluation in the three groups.
| TC ( | MVA ( | CG ( |
| |
|---|---|---|---|---|
| TIMI 3 LAD | 19 (70%) | 22 (81%) | 26 (96%) |
|
| TFC LAD | 22 ± 8 | 20 ± 7 | 15 ± 4 |
|
| TIMI 3 RCA | 27 (100%) | 27 (100%) | 27 (100%) | NS |
| TFC RCA | 12 ± 4 | 13 ± 3 | 10 ± 3 |
|
| TIMI 3 LC | 27 (100%) | 25 (93%) | 27 (100%) | NS |
| TFC LC | 14 ± 4 | 16 ± 4 | 11 ± 3 |
|
TC: Takotsubo cardiomyopathy; MVA: microvascular angina; CG: control group; LAD: left anterior descending coronary artery; RCA: right coronary artery; LC: left circumflex coronary artery; ∗ indicates the same result for all the three matches.
Figure 1TIMI frame count in the LAD, RCA, and LC for the three groups. TC: Takotsubo cardiomyopathy; MVA: microvascular angina; CG: control group; TFC: TIMI frame count; LAD: left anterior descending coronary artery; RCA: right coronary artery; LC: left circumflex coronary artery; NS: nonsignificant.
Myocardial perfusion evaluation in the three groups.
| TC ( | MVA ( | CG ( |
| |
|---|---|---|---|---|
| Blush LAD | 19 (70%) | 27 (100%) | 27 (100%) |
|
| QuBE LAD | 8,9 (7,2–11,5) | 13,5 (10–16) | 11,4 (10–15,7) |
|
| Blush 3 RCA | 26 (96%) | 27 (100%) | 27 (100%) | NS |
| QuBE RCA | 10 (7,7–12,4) | 11 (9–15,4) | 10,5 (7,7–13) | NS |
| Blush 3 LC | 27 (100%) | 26 (96%) | 27 (100%) | NS |
| QuBE LC | 10,4 (7,1–12,8) | 13 (10–17) | 11,5 (9,5–15) | NS |
TC: Takotsubo cardiomyopathy; MVA: microvascular angina; CG: control group; TFC: TIMI frame count; QuBE: Quantitative Blush Evaluator; LAD: left anterior descending coronary artery; RCA: right coronary artery; LC: left circumflex coronary artery; ∗ indicates the same result for all the three matches.
Figure 2Quantitative blush assessment in the LAD, RCA, and LC for the three groups. TC: Takotsubo cardiomyopathy; MVA: microvascular angina; CG: control group; QuBE: Quantitative Blush Evaluator; LAD: left anterior descending coronary artery; RCA: right coronary artery; LC: left circumflex coronary artery; NS: nonsignificant. Red circle: mild outliers; red star: extreme outliers.